About

About InSilicoTrials InSilicoTrials aims to become the premier problem solver in drug development by leveraging computational modeling and simulation (in silico) techniques. Using AI and advanced predictive technologies, we support emerging biotech companies by generating robust digital evidence that enhances funding prospects and clinical outcomes. Our in silico methods reduce R&D time and costs, offering virtual patient and AI-enhanced trial accuracy, cloud-based simulations for comprehensive virtual assessments & regulatory-compliant data to support clinical programs. Our commitment has not gone unnoticed: besides the the AI Startup of the Year Award by Startup Grind Global 2024, we are also proud recipients of the Innovation Radar Prize 2023 by the European Commission in the AI & Smart Devices category. About InSilicoTrials InSilicoTrials aims to become the premier problem solver in drug development by leveraging computational modeling and simulation (in silico) techniques. Using AI and advanced predictive technologies, we support emerging biotech companies by generating robust digital evidence that enhances funding prospects and clinical outcomes. Our in silico methods reduce R&D time and costs, offering virtual patient and AI-enhanced trial accuracy, cloud-based simulations for comprehensive virtual assessments & regulatory-compliant data to support clinical programs. Our commitment has not gone unnoticed: besides the the AI Startup of the Year Award by Startup Grind Global 2024, we are also proud recipients of the Innovation Radar Prize 2023 by the European Commission in the AI & Smart Devices category. InSilicoTrials offers a groundbreaking cloud-based technology platform that generates digital regulatory grade evidence using FDA-supported in silico methodologies. Simulation, predictive intelligence, and AI can be applied to the whole drug development lifecycle, from discovery, clinical trials to commercial strategies. Our platform supports diverse disease areas with cutting-edge models, synthetic patient simulations, and virtual patients while significantly cutting R&D time and costs.